Polynovo Ltd (ASX:PNV)
Share Price & News Healthcare

AUD 1.515 -0.1 (6.192%)

(As on 2023-05-04 08:56:48 AEDT)
Previous Close Open Close* Market Capitalization Dividend Yield Day Range 52 WEEK HIGH LOW
$1.615 $1.6 $1.515 $1.04 B -- $1.47 L $1.62 H $0.85 L $2.71 H

Chart Price & Info

Note: Kalkine Pty Limited (“Kalkine”) may display, include or make available third-party content including charts or any other data (“Third Party Content”) on its website/app. You acknowledge and agree that Kalkine is not responsible for Third Party Content including their accuracy, content, reliability or any other aspect thereof. Kalkine will not accept liability for any loss or damage, including without limitation any loss of profit, which may arise directly or indirectly from use of or reliance on such Third Party Content. All Third Party Content is the exclusive property of their respective owners.

Last Trade 1.515
Change% -6.1920
52 W H/L
EBITDA -4.67 M$
Net Profit
After Abnormals
$-1.19 M
Capital $17.71 M
Return on Equity (ROE) -6.73%
Total Liabilities 17.26 M
Total Revenue 41.89 M
Cash 6.10 M

Stock Information*

Share price 1.515
Market Capitalization 1045096618
Price to Gross Cash Flow 893.32
Dividend Yield Excluding Special 0.00%
Diluted Share outstanding 661.69 M
Gross Dividend Per Share $--
Dividend Yield 0.00%
Earnings Yield 0.040
Net Tangible Assets Per Share 0.02
PE Ratio --
Sector P/E --
Earnings per Share (EPS) (cents) -0.18
EV to EBITDA 1,197.52
Net Profit Margin -2.88%
Gross Cash Flow Per Share $0.00
Net Gearing 27.62%
Sales Per Share $0.06
Book Value Per Share $0.03

Similar Companies

About Company

Company Overview: PolyNovo Limited is a medical device company. The Company designs, develops and manufactures solutions for standalone and combination devices using its NovoSorb biodegradable polymer technology. The Company focuses on medical devices that are used in the treatment of burns, surgical wounds and negative pressure wound therapy (NPWT). It is involved in the development of NovoPore for use as a dressing in NPWT that involves a wound-contacting foam dressing, a sealing membrane, a suction pump, and a drainage tube from the dressing to a canister, and Biodegradable Temporising Matrix (BTM), a wound dressing focused on treatment of full-thickness wounds and burns where the dermal structure has been lost to trauma, or damaged requiring surgical removal, and requires a split-thickness skin graft for final closure. In addition, the Company is engaged in the development of breast sling prototypes for non-clinical and clinical trials, as well as new products for hernia and breast reconstructions.

Corporate Information

company address Unit 2, 320 Lorimer St, Port Melbourne, VIC, 3207

company phonePhone:   +61 3 8681 4050

company emailEmail:  [email protected]

company website Website:   www.polynovo.com

Event Calendar*

Event Type Event Date Event Year
Report (Interim) 2024-02-28 2024 upcoming
Report (Interim) 2024-02-22 2024 upcoming
Report (Annual) 2023-09-20 2023
Report (Annual) 2023-08-25 2023
Report (Prelim) 2023-08-25 2023


© Data powered by Morningstar, Inc. 2023. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.